Takashi Sasayama

12PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunology not elsewhere classifiedRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 18, 2026
A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART).

|May 18, 2026
Cerebrospinal fluid soluble protein tyrosine phosphatase receptor type Z detected with human natural killer-1 antibody as a practical biomarker for glioma diagnosis.

|Feb 23, 2026
Ketogenic diet therapy for high-grade gliomas combined with standard treatment using an angiogenesis inhibitor: An exploratory pilot study on feasibility.

Takashi Sasayama, Kazuhiro Tanaka, Hiroaki Nagashima

|Jul 28, 2025
Tumor-mimicking sarcoid-like reaction with lymphoid infiltration showing intracranial extension from the left jugular foramen: illustrative case.

Young Ju Kim, Masamitsu Nishihara, Hirofumi Iwahashi

|Jul 11, 2025
Endovascular treatment of spinal dural arteriovenous fistulas with multiple segment catheterization approach.

Atsushi Fujita, Masaaki Kohta, Takashi Sasayama

|Nov 04, 2024
Clinical Benefits of Photodynamic Therapy Using Talaporfin Sodium in Patients With Isocitrate Dehydrogenase -Wildtype Diagnosed Glioblastoma: A Retrospective Study of 100 Cases.

Yosuke Fujimoto, Yuichi Fujita, Kazuhiro Tanaka

Pageof 2

Frequent Collaborators

3 joint publications

Kazuhiro Tanaka

3 joint publications

Masaaki Kohta

3 joint publications

Atsushi Fujita

2 joint publications

Hiroaki Nagashima